They suggest that TLR2 is a direct transcriptional target of STAT3; additionally, they draw attention to the data of patients with gastric cancer in whom increased activation of the STAT3 pathway, as well as TLR2 expression, negatively affect the survival of the affected person [23]. Here, STAT3 is linked to gastric cancer.